Neurodegenerative diseases are a group of disorders that cause the progressively degeneration and death of nerve or brain cells. These diseases cause physical and mental disability and can even lead to death. Neurodegenerative diseases encompass a wide variety of different conditions, including Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Huntington’s disease. These conditions can be inherited, or can be caused by environmental factors. The common feature among them is the gradual loss of neurons, the specialized cells in the brain and central nervous system that transmit information. The cause of most neurodegenerative diseases is not yet known, but there is some evidence suggesting that a combination of genetic and environmental factors could contribute to its development. Certain genetic mutations have been linked to certain neurodegenerative diseases, indicating a possible hereditary component. In addition, research suggests that lifestyle habits such as lack of physical activity, smoking, and consuming an unhealthy diet may also play a role in the development of some of these conditions. The symptoms of neurodegenerative diseases can vary widely from person to person. Some of the most common symptoms include muscle weakness, speech difficulties, memory loss, impaired movement, changes in behavior, and difficulty with basic coordination. In addition, many of these diseases can cause a person to lose their independence and their ability to perform everyday tasks as the disease progresses. There is currently no cure for neurodegenerative diseases. Treatment focuses on managing symptoms and helping a person maintain as much mobility and independence as possible. Current therapies include medication, physical therapy, and support groups. While these treatments will not reverse the damage already done, they can help to improve the quality of life for those living with these conditions.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom